While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company that's been ...

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where UnitedHealth Group Incorporated ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

WisdomTree U.S. SmallCap Dividend Fund offers a 2.8% yield but underperforms peers, with a sector allocation impacting growth potential. Learn more on DES stock here.

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

In a report released on January 27, Naz Rahman from Maxim Group reiterated a Buy rating on Silexion Therapeutics (SLXN – Research Report), with ...

Sagility acquires BroadPath Healthcare Solutions, adding 30+ clients and enhancing operations with Bhive platform and ...

Alterity Therapeutics ATHE shares moved upwards by 95.9% to $5.7 during Thursday's pre-market session. The market value of their outstanding shares is at $49.8 million. T ...

The report concluded with a positive outlook on Quest Diagnostics (NYSE:DGX)' future, noting its improving growth trajectory and the protective buffer it has against challenges in the healthcare ...